PSGH Urges Public to Stop Antibiotic Misuse


The Pharmaceutical Society of Ghana (PSGH) has urged Ghanaians to avoid using antibiotics for common conditions such as flu, colds, coughs, and diarrhea, emphasizing the dangers of antimicrobial resistance (AMR). Speaking at a press conference during the 2024 World Antimicrobial Resistance Awareness Week (WAAW), Pharm. Dr. Samuel Kow Donkoh, PSGH President, warned against self-medication with antibiotics and stressed the importance of appropriate treatment and testing.


Dr. Donkoh noted that flu and colds are caused by viruses and only require over-the-counter medications for symptom relief, while most cases of coughs and sore throats can be managed with lozenges. Diarrheal diseases, particularly in children, are best treated with oral rehydration salts (ORS) and zinc tablets unless severe, in which case hospitalization is needed.


He also emphasized testing for malaria before taking antimalarials, urging the public to consult pharmacists for guidance. "Antimicrobial resistance threatens the effectiveness of treatments, prolongs illnesses, increases mortality, and raises healthcare costs," he said. Globally, AMR could claim up to 10 million lives annually by 2050 if unchecked.


Contributing factors include misuse of antimicrobials, inadequate infection prevention, and poor sanitation. Dr. Donkoh highlighted the need for collective action through education, advocacy, and immediate measures to combat AMR under this year’s WAAW theme: Educate. Advocate. Act Now.


The PSGH reaffirmed its commitment to combating AMR through pharmacist training, community engagement, and partnerships with government and international organizations. Dr. Donkoh concluded by calling for a united effort to safeguard the effectiveness of antimicrobials and protect future generations.




Comments

Popular posts from this blog

Chieftaincy Crisis: Ngleshie Alata Chiefs Reject Imposed Mantse

Royal Jamong Family Raises Alarm Over Alleged Political Interference in Bunkpurugu Chieftaincy Dispute

Electrochem’s Ada Salt Deal in Jeopardy